Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

ABO Antibody Titer Testing Harmonization in Korea: A 5-Year Analysis of External Quality Control Data

  • Han Joo Kim (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Yousun Chung (Department of Laboratory Medicine, Kangdong Sacred Heart Hospital) ;
  • Sang-Hyun Hwang (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Heung-Bum Oh (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hyungsuk Kim (Department of Laboratory Medicine, Seoul National University Hospital) ;
  • Dae-Hyun Ko (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2024.10.02
  • Accepted : 2025.03.01
  • Published : 2025.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Current ABO titration methods lack standardization and harmonization. We analyzed the consistency of ABO antibody titer testing among Korean laboratories and discussed future directions for standardization by analyzing external quality control data collected by the Korean Association of External Quality Assessment Service over 5 yrs (2019-2023). The analysis included the number of participating institutions and methods, as well as the proportion of acceptable results. To compare column agglutination technology (CAT) and tube methods, we created a normalized variable: ([log2 titer of laboratory test result]-[mean of log2 titer for the peer group]). The number of participating institutions and methods increased over time. The use of CAT methods expanded, whereas that of tube methods declined. The proportion of acceptable results ranged from 84.0% to 100%, with no significant differences between CAT and tube methods. An F-test revealed no significant variance differences among institutions using these methods. Tube methods demonstrated lower variance in anti-human globulin testing, and room temperature tube methods exhibited lower variance than that of CAT methods. Domestic laboratories demonstrated high-quality performance in ABO antibody titer testing, with no significant differences in acceptable result rates or variance across methods. Continuous efforts toward standardization remain essential.

Keywords

References

  1. Alexandre GP, Squifflet JP, De Bruyère M, Latinne D, Reding R, Gianello P, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987;19:4538–42.
  2. Kim H, Choe W, Shin S, Kim YH, Han DJ, Park SK, et al. ABO-incompatible kidney transplantation can be successfully conducted by monitoring IgM isoagglutinin titers during desensitization. Transfusion 2020;60: 598–606. https://doi.org/10.1111/trf.15672
  3. Ministry of Health and Welfare. In. National Institute of Organ, Tissue, and Blood Management. Annual Report of the Transplant 2022. Seoul, South Korea, 2023. (https://www.konos.go.kr/board/boardListPage.do?page=sub4_2_1&boardId=30) (Updated on Feb 2025)
  4. Urschel S and West LJ. ABO-incompatible heart transplantation. Curr Opin Pediatr 2016;28:613–9. https://doi.org/10.1097/MOP.0000000000000398
  5. Böhmig GA, Farkas AM, Eskandary F, Wekerle T. Strategies to overcome the ABO barrier in kidney transplantation. Nat Rev Nephrol 2015;11: 732–47. https://doi.org/10.1038/nrneph.2015.144
  6. Kim HJ, Chung Y, Kim H, Ko DH. Clinical significance of IgM and IgG isoagglutinins in ABO-incompatible solid organ transplantation: Insights from materno-fetal immunoglobulin status. Transfus Apher Sci 2023; 62:103786. https://doi.org/10.1016/j.transci.2023.103786
  7. Kim HJ, Chung Y, Kim H, Ko Y, Kim YH, Hwang S-H, et al. Long-term isoagglutinin monitoring after ABO-incompatible kidney transplantation. Am J Clin Pathol 2025;163:290–7. https://doi.org/10.1093/ajcp/aqae122
  8. Gaines BA, Yazer MH, Triulzi DJ, Sperry JL, Neal MD, Billiar TR, et al. Low titer group O whole blood in injured children requiring massive transfusion. Ann Surg 2023;277:e919–24. https://doi.org/10.1097/SLA.0000000000005251
  9. Orr MD, Casleton BG, Garcia OR. Comparison of manual titrations to automated microplate and gel titration assays used in the screening of blood donors for production of low-titer O whole blood. Transfusion 2024;64:1993–2000. https://doi.org/10.1111/trf.17953
  10. AuBuchon JP, de Wildt-Eggen J, Dumont LJ, Biomedical Excellence for Safer Transfusion Collaborative, Transfusion Medicine Resource Committee of the College of American Pathologists. Reducing the variation in performance of antibody titrations. Arch Pathol Lab Med 2008;132: 1194–201. https://doi.org/10.5858/2008-132-1194-RTVIPO
  11. Lim YA and Kang SJ. Standardization of ABO antibody titer measurement at laboratories in Korea. Ann Lab Med 2014;34:456–62. https://doi.org/10.3343/alm.2014.34.6.456
  12. Bachegowda LS, Cheng YH, Long T, Shaz BH. Impact of uniform methods on interlaboratory antibody titration variability: antibody titration and uniform methods. Arch Pathol Lab Med 2017;141:131–8. https://doi.org/10.5858/arpa.2015-0351-OA
  13. Kim HJ, Chung Y, Kim H, Hwang SH, Oh HB, Ko DH. Analysis of unacceptable results in proficiency testing for general transfusion medicine tests. J Lab Med Qual Assur 2023;45:115–9. https://doi.org/10.15263/jlmqa.2023.45.3.115
  14. Health Insurance Review & Assessment Service. Open Data Portal https://opendata.hira.or.kr/ (Updated on Feb 2025)
  15. Bhangale A, Pathak A, Pawar S, Jeloka T. Comparison of antibody titers using conventional tube technique versus column agglutination technique in ABO blood group incompatible renal transplant. Asian J Transfus Sci 2017;11:131–4. https://doi.org/10.4103/0973-6247.214343
  16. Plebani M and Lippi G. Standardization and harmonization in laboratory medicine: not only for clinical chemistry measurands. Clin Chem Lab Med 2023;61:185–7. https://doi.org/10.1515/cclm-2022-1122
  17. Yoon YA, Lee YW, Kim S, Lee K, Park HD, Chun S, et al. Standardization status of total cholesterol concentration measurement: analysis of Korean External Quality Assessment Data. Ann Lab Med 2021;41:366–71. https://doi.org/10.3343/alm.2021.41.4.366
  18. Yang JJ, Chung Y, Kim H, Ko DH, Hwang SH, Oh HB. Retrospection of anti-blood group antibody proficiency testing data using the geometric mean and standard deviation. Am J Clin Pathol 2020;153:530–6. https://doi.org/10.1093/ajcp/aqz187
  19. Yang JJ, Youk HJ, Chung Y, Kim H, Hwang SH, Oh HB, et al. Application of geometric mean criteria for anti-blood group antibody proficiency testing in the Korean external quality assurance program. J Lab Med Qual Assur 2022;44:48–54. https://doi.org/10.15263/jlmqa.2022.44.1.48
  20. Youk HJ, Ryu HY, Seo SW, Kim JS, Chung Y, Kim H, et al. A new trial to measure ABO antibodies using complement-dependent cytotoxicity. Medicina (Kaunas) 2022;58:830. https://doi.org/10.3390/medicina58060830